JD’s third unicorn was valued at USD 7 billion after a Series A fundraising in November 2019.
JD Health is planning an IPO on the Hong Kong Stock Exchange, according to people familiar with the matter. It plans to raise at least USD 1 billion by the end of 2020 or the beginning of 2021.
This year, JD Group has made many eye-catching moves on the public market. Earlier this June, Dada group (DADA:Nasdaq), controlled by the JD group, went to the US Nasdaq market this June. Following that, JD.com went back to the Hong Kong Stock Exchange for second public fundraising. At the beginning of July, JD Digits started the pre-listing tutoring.
JD Health primarily covers four areas: pharmaceutical e-commerce, Internet medication, healthcare services and smart solutions based on the concept of Healthcare + Internet.
Compared to other healthcare platforms listed on Hong Kong Stock Exchange, such as Ali Health (00241:HKEX) and Ping An Good Doctor (01833:HKEX), both valued at tens of millions of HK dollars, JD Health has a long way to go.